Jan Hoffmeyer

Papers

Total Citations

H-Index

About

Dr. Jan Hoffmeyer is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with advanced kidney cancer. His major contributions center on comparing the efficacy and safety of minimally invasive versus open surgical approaches for renal cell carcinoma. In his landmark 2016 study, "Outcomes of Minimal Invasive vs Open Radical Nephrectomy for the Treatment of Locally Advanced Renal-Cell Carcinoma," Dr. Hoffmeyer demonstrated that minimally invasive techniques can achieve comparable oncologic outcomes to open surgery for locally advanced disease, challenging traditional surgical paradigms. This work, which has garnered 47 citations, has helped guide clinical decision-making for complex nephrectomies. He further expanded this evidence base through a multi-institutional analysis of minimally invasive cytoreductive nephrectomy, a critical procedure for metastatic kidney cancer patients, which has been cited 21 times. Dr. Hoffmeyer’s research is notable for its rigorous methodology, utilizing prospectively maintained databases from a National Comprehensive Cancer Network-designated center. His findings have directly influenced surgical practice, offering patients less invasive options without compromising cancer control, and establishing him as a key voice in the evolution of urologic oncology surgery.